A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

Clinical trial NCT06526923 · RECRUITING

Trial details

NCT number: NCT06526923
Sponsor: Spirovant Sciences, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2024-09-16
Primary completion: 2026-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.